SG Americas Securities LLC Sells 13,249 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

SG Americas Securities LLC decreased its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 25.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,346 shares of the company’s stock after selling 13,249 shares during the period. SG Americas Securities LLC’s holdings in AdaptHealth were worth $375,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. The Manufacturers Life Insurance Company lifted its position in AdaptHealth by 8.1% during the second quarter. The Manufacturers Life Insurance Company now owns 39,440 shares of the company’s stock worth $394,000 after acquiring an additional 2,959 shares during the last quarter. Mutual of America Capital Management LLC increased its stake in AdaptHealth by 23.8% in the third quarter. Mutual of America Capital Management LLC now owns 15,893 shares of the company’s stock valued at $178,000 after acquiring an additional 3,052 shares during the last quarter. LRI Investments LLC increased its stake in AdaptHealth by 32.0% in the third quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock valued at $172,000 after acquiring an additional 3,713 shares during the last quarter. Glenmede Trust Co. NA grew its stake in shares of AdaptHealth by 38.3% during the third quarter. Glenmede Trust Co. NA now owns 16,453 shares of the company’s stock worth $185,000 after buying an additional 4,556 shares during the last quarter. Finally, Quarry LP grew its stake in shares of AdaptHealth by 4,596.9% during the third quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after buying an additional 5,838 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Down 5.4 %

AHCO opened at $10.24 on Tuesday. The company has a 50 day moving average of $10.02 and a 200 day moving average of $10.37. The company has a market cap of $1.38 billion, a PE ratio of -6.21, a price-to-earnings-growth ratio of 1.38 and a beta of 1.09. AdaptHealth Corp. has a 12 month low of $6.91 and a 12 month high of $11.90. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.02). AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The firm had revenue of $805.90 million during the quarter, compared to the consensus estimate of $809.32 million. During the same period in the previous year, the business earned $0.19 earnings per share. The firm’s revenue for the quarter was up .2% on a year-over-year basis. On average, sell-side analysts expect that AdaptHealth Corp. will post 0.88 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on AHCO shares. Canaccord Genuity Group reduced their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Robert W. Baird dropped their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. UBS Group dropped their price target on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. Truist Financial dropped their price target on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, November 15th. Finally, Royal Bank of Canada decreased their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research note on Tuesday, November 19th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $12.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.